<DOC>
	<DOCNO>NCT00418834</DOCNO>
	<brief_summary>A 12 week clinical trial patient 65 year age old hypercholesterolemia high risk coronary heart disease study effect atorvastatin ezetimibe give combination two high dos atorvastatin lipid lowering .</brief_summary>
	<brief_title>Ezetimibe Atorvastatin vs. Atorvastatin Patients Age 65 Older High Risk Coronary Heart Disease ( CHD ) ( 0653-112 )</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>Patient age 65 old Patient willing maintain cholesterol lower diet Patient hyperlipidemia LDL level great 70 mg/dl 100 mg/dl depend CHD risk category A condition , opinion investigator , would pose risk patient interfere participation study Patient unlikely compliant take study medication Patient chronic unstable medical condition Patient take unstable dos medication Patient drink 2 alcoholic drink per day Patient elevation certain laboratory value ( CK , AST , ALT )</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>